ResearchWorks Archive
    • Login
    View Item 
    •   ResearchWorks Home
    • Dissertations and Theses
    • Pharmaceutics
    • View Item
    •   ResearchWorks Home
    • Dissertations and Theses
    • Pharmaceutics
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Mathematical Models to Evaluate the Clinical and Economic Impact of Biomedical HIV Prevention Strategies in the United States

    Thumbnail
    View/Open
    Adamson_washington_0250E_18258.pdf (6.779Mb)
    Author
    Adamson, Blythe
    Metadata
    Show full item record
    Abstract
    As the marginal clinical impact returns on innovations to treat and prevent HIV diminish, strategic investments are required for timely and efficient HIV eradication. The overall goal of this dissertation research is to evaluate the potential cost-effectiveness of several pharmacotherapy-related interventions included in the National HIV/AIDS Strategy for the United States in order to inform decision-making and policy design. Rising HIV program costs along with poor results in patient access and service utilization make determining the value of new HIV interventions very important for the vulnerable populations bearing the disease burden. Today, pre-exposure prophylaxis (PrEP) drugs are a short-term solution. Quite soon, programs offering financial incentives for viral suppression are expected to expand. Over the long term, many view the development of a safe and effective HIV vaccine as the only hope to completely eradicate AIDS. I develop a series of mathematical models to examine the clinical and economic impact of financial incentives, PrEP, and HIV vaccines using local and national surveillance data drawing on the results of large clinical trials. Importantly, I examine the potential interaction and competition between PrEP and HIV vaccines which needs to be understood to achieve optimal benefit from the combined use of the two in the coming decades. Lastly, I make policy and R&D investment recommendations aimed to support efficient progress towards the national strategic goals.
    URI
    http://hdl.handle.net/1773/42086
    Collections
    • Pharmaceutics [63]

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchWorksCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    @mire NV